Abstergo is working on combating Ebola with new drugs. The new drug will create antibodies designed to attack and kill the Ebola virus. It will also help strengthen the body’s immune system so the patient has a better chance of fighting the virus. The blood of surviving patients is being analyzed for further research. The blood of a survivor when transferred to an infected patient will boost the survival rate of the sick patient; Abstergo is looking into this further and trying to duplicate it synthetically. We are also working on creating better protection for health care workers who may have to respond and treat infected people.
Category Archives: Medicine and drugdevelopment
Brain reconstruction
Our brain is the key to our existence and mostly a mystery to scientists but with all the data gathered form our extensive and ongoing animus experiments and observations our scientists are mapping the brain in details not previously seen. We are currently collecting data on how each part of the brain functions and how best to copy the signals created by the brain for reconstruction purposes. Imagine when we can completely eradicate mental illness simply by re-wiring our brain and filling in gaps. So far researchers have only been able to map small segments of the brain but Abstergo will be the first to map the entire brain. We are creating a revolutionary image of the brain that shows how cells and complex neural circuits interact in both time and space.
For more information check out the BRAIN Initiative.
Career opportunities at Abstergo
The work fields at Abstergo are extremely varied. Do you want to work with other people as an employee in Customer Services? Or would you prefer to help in the Research and Development Department? Or would you prefer to be a Editor in our Editorial Department?
As one of the largest employers in the field of medicine, research and telecommunications Abstergo offers not only a job with good career opportunities, but also a friendly working atmosphere, clear hierarchies, autonomous work planning and other services.
If you have always wanted to work with an international team from all over the world you are right at Abstergo!
To see the open jobs go to the “Careers” Page where you can find the open positions!
Blind Cure
Just to keep you up to date, our “lab-boys” are working on a cure that may or may not cure blindness. So far tests have been responsive on increasing a sense of path finding, but so much as to seeing just yet. We are really close to getting it done, specially now that we have done some development on the electronic nose, this will really help and improve the Blind cure more.
Blood key to Suicide Prediction
Abstergo’s contribution to medical neuroscience research has led to a discovery that a certain molecule made by the gene SAT1 may be linked to suicide. Subjects with a higher tendency to exhibit suicidal behavior showed elevated levels of the gene SAT1, a gene involved with cell death. During testing, several biological molecules in the blood of our subjects changed including the SAT1 gene.
Right now doctors rely on people telling them their feelings and symptoms to detect suicide. With the development of a blood test doctors will be able to detect clients in immediate danger. See the full research, published in the journal Molecular Psychiatry.
To The Concerned Public
It has come to our attention speculations that Abstergo is obtaining genetic code know as DNA without consent of its owner. There has also been talk that we are building a secret DNA library without public notification or consent.
This is all false information; we at Abstergo adhere to strict rules and only obtain DNA or any other genetic information through extensive contracts that are signed willing by our generous volunteers. Depending on our work and the contract signed by our volunteer, we dispose of any genetic information obtained during testing once we are finished. We thank you for your patients while we sort this out, for more information please call our public relations desk.
Antibiotic Resistance and the Animus
With the announcement of a-OS 4.0, Abstergo has been fielding a number of questions from the public, but the most common is why a company with a main focus on pharmaceutical development needs to explore the past in such great detail with the Animus.
Abstergo is committed to solving the toughest riddles in the medical community, with the most critical focus on eliminating antibiotic-resistant bacteria and super viruses. We know that rapid DNA mutations within these types of bacteria and viruses are what cause them to be resistant to pharmaceutical treatment, and that finding a way to stop these mutations from occurring will be the key to eliminating them. Our scientists believe that uncovering the source of a particular virus and tracking its progress throughout history will allow us to map its mutations and discover a pattern or common occurrence. By tracking more than one at a time, we can see if there is a similar pattern that spreads across all mutations. With the Animus, not only can we truly see history as it unfolds, but also retrieve accurate, first-hand data of the progress of human diseases.
Abstergo’s ultimate goal, however, is to develop a nanobot that can be administered to a patient orally in a pill. Once in the patient’s system, it will be able to identify, track, study, and destroy any infection from a common cold to cancer!
